Metacognitive Therapy Self-Help for Anxiety-Depression: Single-Blind Randomized Feasibility Trial in Cardiovascular Disease
Overview
This paper reports on a single-blind randomized feasibility trial evaluating assisted home-based self-help metacognitive therapy (home-MCT) for cardiovascular disease patients with anxiety and depression. The study assessed the intervention's acceptability, recruitment rates, and completion levels among cardiac rehabilitation participants in the UK. It concludes that home-MCT is a feasible delivery method, though it notes lower-than-expected quality in telephone support calls provided by staff.
- ID
2e28488b95664ea3- Source org
- PubMed Central
- Author
- Not recorded
- Published
- Not recorded
- OA status
- Not recorded
- DOI
- 10.1037/hea0001168
- PMID
- Not recorded
- PMCID
- Not recorded
- Citations
- Not recorded
Tags
Verification
- identityok via crossref · score 1 · checked_at unknown
- legitimacykeep via unknown · score 1 · checked_at unknown
- linkok via http-check · 2026-07-28T03:58:44.050956+00:00
Cite this entry
BibTeX
@article{allodium:2e28488b95664ea3,
title = {Metacognitive Therapy Self-Help for Anxiety-Depression: Single-Blind Randomized Feasibility Trial in Cardiovascular Disease},
journal = {PubMed Central},
doi = {10.1037/hea0001168},
url = {https://doi.org/10.1037/hea0001168}
}RIS
TY - JOUR TI - Metacognitive Therapy Self-Help for Anxiety-Depression: Single-Blind Randomized Feasibility Trial in Cardiovascular Disease PB - PubMed Central DO - 10.1037/hea0001168 UR - https://doi.org/10.1037/hea0001168 ER -
APA
Metacognitive Therapy Self-Help for Anxiety-Depression: Single-Blind Randomized Feasibility Trial in Cardiovascular Disease. (n.d.). PubMed Central. https://doi.org/10.1037/hea0001168
Related entries
- Metacognitive therapy home-based self-help for cardiac rehabilitation patients experiencing anxiety and depressive symptoms: study protocol for a feasibility randomised controlled trial (PATHWAY Home-MCT)
- Evaluating Metacognitive Therapy to Improve Treatment of Anxiety and Depression in Cardiovascular Disease: The NIHR Funded PATHWAY Research Programme
- Metacognitive therapy home-based self-help for anxiety and depression in cardiovascular disease patients in the UK: A single-blind randomised controlled trial
- Establishing the Feasibility of Group Metacognitive Therapy for Anxiety and Depression in Cardiac Rehabilitation: A Single-Blind Randomized Pilot Study
- Improving the Effectiveness of Psychological Interventions for Depression and Anxiety in Cardiac Rehabilitation
- Cardiac rehabilitation patients experiences and understanding of group metacognitive therapy: a qualitative study
- Improving the effectiveness of psychological interventions for depression and anxiety in the cardiac rehabilitation pathway using group-based metacognitive therapy (PATHWAY Group MCT): study protocol for a randomised controlled trial
- Cost-effectiveness of metacognitive therapy for cardiac rehabilitation participants with symptoms of anxiety and/or depression: analysis of a randomised controlled trial
- Qualitative Analysis of Emotional Distress in Cardiac Patients From the Perspectives of Cognitive Behavioral and Metacognitive Theories: Why Might Cognitive Behavioral Therapy Have Limited Benefit, and Might Metacognitive Therapy Be More Effective?
- Protocol for the economic evaluation of metacognitive therapy for cardiac rehabilitation participants with symptoms of anxiety and/or depression